15,000 second chances: Bone Marrow Transplant program celebrates new milestone

April 24, 2019 | Michael Easterling and Samantha Bonar

City of Hope’s bone marrow transplant program recently performed the procedure on its 15,000th patient, a remarkable milestone considering that the initiative started with just two physicians, three beds and guarded expectations in 1976.

Continue Reading

Finding better treatments for devastating rare diseases

February 27, 2019 | Abe Rosenberg

City of Hope has long been renowned for its expertise in treating cancer and diabetes. But specialists here also are tackling lesser-known but equally devastating diseases that may or may not have an oncologic component.

Grad student leads groundbreaking study for neurodegenerative disease

October 4, 2018 | Maxine Nunes

As a Ph.D. candidate at City of Hope, Li Li's work with Alexander disease may also shed new light on similar neurodegenerative conditions such as Alzheimer’s, Parkinson’s and amyotrophic lateral sclerosis.

City of Hope scientist's stem cell model could be key to slowing Alzheimer's

September 28, 2018 | Zen Vuong

Treatments for a rare nervous system disorder and, eventually, Alzheimer's disease could be influenced by new research conducted by City of Hope's Yanhong Shi, Ph.D.

New stem cell model could be key to slowing Alzheimer's disease

August 3, 2018 | Zen Vuong

City of Hope's Yanhong Shi, Ph.D., developed a stem cell model to test treatments for a rare nervous system disorder and, eventually, Alzheimer's disease.

Students Today, Scientists Tomorrow: Interns Shine in the City of Hope Spotlight

September 6, 2017 | Michael Easterling

Students spent 10 weeks this summer at the Eugene and Ruth Roberts Summer Student Academy, designed to give hardworking students the opportunity to learn about science by working in a laboratory setting.

$7.38 million grant will benefit new treatments for fatal childhood disease

March 17, 2016 | City of Hope

City of Hope's efforts to fight and cure Canavan disease — a rare yet fatal disorder that strikes within the first three to four months of an infant's life — just got a $7.38 million boost from the California Institute for Regenerative Medicine.

Study: Researchers develop new method of targeting cancer stem cells

March 3, 2016 | Letisia Marquez

Research into a promising therapeutic target for glioblastoma was recently published in the journal Nature Communications. City of Hope scientists are working to uncover how cancer stem cells grow, and what can be done to stop them from multiplying.